Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Grant | $33,975 | 4 | 91.6% |
| Food and Beverage | $2,889 | 170 | 7.8% |
| Education | $237.94 | 3 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Cook Medical LLC | $21,551 | 4 | $0 (2020) |
| Boston Scientific Corporation | $12,586 | 2 | $0 (2020) |
| ABBVIE INC. | $958.38 | 69 | $0 (2024) |
| Janssen Biotech, Inc. | $516.11 | 21 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $334.10 | 18 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $216.10 | 12 | $0 (2024) |
| GENZYME CORPORATION | $148.46 | 8 | $0 (2024) |
| Braintree Laboratories, Inc. | $115.95 | 6 | $0 (2023) |
| QOL Medical, LLC | $103.71 | 6 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $95.11 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,115 | 62 | ABBVIE INC. ($269.99) |
| 2023 | $779.91 | 45 | AbbVie Inc. ($199.26) |
| 2022 | $670.69 | 45 | ABBVIE INC. ($346.59) |
| 2021 | $305.53 | 18 | AbbVie Inc. ($142.54) |
| 2020 | $33,750 | 2 | Cook Medical LLC ($21,250) |
| 2019 | $236.00 | 2 | Cook Medical LLC ($150.00) |
| 2018 | $150.50 | 2 | Cook Medical LLC ($150.50) |
| 2017 | $93.95 | 1 | Janssen Biotech, Inc. ($93.95) |
All Payment Transactions
177 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Gastroenterology | ||||||
| 12/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $10.02 | General |
| Category: Immunology | ||||||
| 11/26/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $7.29 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: Gastroenterology | ||||||
| 11/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/22/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Food and Beverage | In-kind items and services | $26.94 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.30 | General |
| Category: Immunology | ||||||
| 10/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Immunology | ||||||
| 10/08/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: IMMUNOLOGY | ||||||
| 10/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Immunology | ||||||
| 09/26/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/24/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: Rare Disease | ||||||
| 09/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: Immunology | ||||||
| 09/23/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $5.99 | General |
| Category: IMMUNOLOGY | ||||||
| 09/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $5.52 | General |
| Category: IMMUNOLOGY | ||||||
| 08/21/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/29/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Immunology | ||||||
| 07/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 106 | 110 | $52,641 | $10,922 |
| 2022 | 5 | 96 | 100 | $46,962 | $10,246 |
| 2021 | 5 | 90 | 91 | $83,594 | $10,236 |
| 2020 | 1 | 17 | 17 | $15,385 | $1,564 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 30 | 30 | $14,630 | $3,682 | 25.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 24 | 24 | $15,696 | $2,841 | 18.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 17 | 19 | $7,148 | $1,753 | 24.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 24 | 25 | $10,775 | $1,622 | 15.1% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 11 | 12 | $4,392 | $1,024 | 23.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $11,704 | $2,854 | 24.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 22 | 22 | $14,388 | $2,810 | 19.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 23 | 25 | $10,775 | $2,151 | 20.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 11 | 13 | $4,891 | $1,297 | 26.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 16 | 16 | $5,205 | $1,134 | 21.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 23 | 23 | $11,216 | $2,991 | 26.7% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 12 | 12 | $18,052 | $2,280 | 12.6% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 22 | 22 | $27,750 | $2,189 | 7.9% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 20 | 21 | $14,811 | $1,698 | 11.5% |
| 43235 | Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 13 | 13 | $11,765 | $1,079 | 9.2% |
| 43235 | Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 17 | 17 | $15,385 | $1,564 | 10.2% |
About Dr. Michael Weaver, MD
Dr. Michael Weaver, MD is a Gastroenterology healthcare provider based in Twin Falls, Idaho. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2013. The National Provider Identifier (NPI) number assigned to this provider is 1720427974.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Weaver, MD has received a total of $37,101 in payments from pharmaceutical and medical device companies, with $1,115 received in 2024. These payments were reported across 177 transactions from 25 companies. The most common payment nature is "Grant" ($33,975).
As a Medicare-enrolled provider, Weaver has provided services to 309 Medicare beneficiaries, totaling 318 services with total Medicare billing of $32,968. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology, General Practice
- Location Twin Falls, ID
- Active Since 06/20/2013
- Last Updated 01/09/2026
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1720427974
Products in Payments
- GENERAL - BILIARY DEVICES (Device) $12,500
- RINVOQ (Biological) $402.16
- DUPIXENT (Biological) $364.56
- STELARA (Biological) $336.55
- HUMIRA (Biological) $303.82
- ENTYVIO (Biological) $293.29
- SKYRIZI (Biological) $208.91
- SUTAB (Drug) $99.19
- OCALIVA (Drug) $95.11
- REMICADE (Biological) $93.95
- IBSRELA (Drug) $92.18
- SUCRAID (Drug) $89.52
- GENERAL BILIARY DEVICES (Device) $86.00
- TREMFYA (Drug) $85.61
- CIMZIA (Drug) $45.96
- Livmarli (Drug) $37.80
- GATTEX (Drug) $35.81
- FERAHEME (Drug) $32.41
- ZEPOSIA (Drug) $32.08
- XIFAXAN (Drug) $29.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Twin Falls
Judith Csanky, Md, MD
Gastroenterology — Payments: $3,441
Seth Wheeler, Md, MD
Gastroenterology — Payments: $2,979
Ted Rea, M.d, M.D
Gastroenterology — Payments: $2,472
Robert Ward, M.d, M.D
Gastroenterology — Payments: $1,106
Dr. Imad Jaafar, Md, MD
Gastroenterology — Payments: $108.21